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Vaginal deliveryAbstract Bioadhesive ﬁlms using tamarind seed polysaccharide were prepared for the treatment of
candida vaginitis using nystatin as the model drug. Films were prepared by solvent casting method.
A 32 factorial design was employed to study the effect of independent variables (polymer and plas-
ticizer concentration) on a range of dependent variables namely mechanical, swelling, interfacial,
and bioadhesive properties through response surface methodological approach, using Design
Expert software. Formulation composition that provided the most desired and optimized results
was selected using desirability approach. Nystatin was solubilized using Tween 60 and was incor-
porated into the selected ﬁlm. Drug solubilization and dispersion were conﬁrmed by scanning elec-
tron microscopy and differential scanning calorimetry. The optimized ﬁlm released 73.92 ± 2.54%
of nystatin at the end of 8 h in simulated vaginal ﬂuid and the release data showed best ﬁt to
Korsmeyer–Peppas model with R2 of 0.9990 and the release mechanism to be super case-II. The
optimized ﬁlm also showed appropriate anti candida activity through appearance of zone of inhi-
bition during antifungal activity testing study.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
).1. Introduction
Polymers derived from natural sources have been reported to
possess versatile applications in biomedical andpharmaceuticals. Their availability in abundance, renewability,
safety and biocompatible nature has encouraged the formula-
tion scientist to substitute them for synthetic additives.
Further, the presence of large number of reactive functional
groups on the polymeric backbone of polysaccharides endows
them with inherent bioadhesive potential. Natural polysaccha-
ridic bioadhesive ﬁlms as dosage forms are receiving consider-
able attention in the pharmaceutical industry as novel, patient
compliant and convenient products due to their small size and
thickness (Hariharan and Bogue, 2009; Lee and Chien, 1995;
Li et al., 1998; Peh and Wong, 1999). Moreover, ease of man-
ufacturing, cost effective method of preparation andnd opti-
2 P. Bassi, G. Kaurbiocompatible nature of these ﬁlms have promoted their appli-
cability for both local and systemic delivery of therapeutic
agents.
Tamarind Seed Polysaccharide (TSP) is derived from seed
kernels of Tamarind (Tamarindus indica L.), belonging to fam-
ily Leguminosae, a plant indigenous to India, Bangladesh,
Myanmar, Sri Lanka, Malaysia, and Thailand (El-Siddig
et al., 2006). The TSP structure comprises of b (1ﬁ4)-D-
glucan backbone, substituted at position 6 of the glucopyra-
nosyl units mainly by single a-D-xylopyranosyl residues as well
as by disaccharide side chains composed of b-D-galactopyrano
syl-(1ﬁ2)-a-D-xylopyranosyl residues (Patel et al., 2008). TSP
is a high molecular weight polysaccharide (720–880 kDa), con-
taining glucose, xylose and galactose units, in a molecular ratio
of 3:2:1 (Freitas et al., 2005). TSP has been reported to pos-
sess mucoadhesive (Sahoo et al., 2010) and control release
properties (Sumathi and Alok, 2002). It has been employed
in the textile printing as a thickener (Abo-Shosha et al.,
2008) and in food industry as a thickening, stabilizing and gel-
ling agent (Nishinari et al., 2000).
Candida vaginitis is one of the most commonly occurring
infection affecting the majority of women during their lifetime.
The vast incidence of this infection has stimulated the need for
the development of therapeutic strategies that ensure success-
ful eradication of the infection while maintaining the safety
and therapeutic efﬁcacy of the formulation and avoid prob-
lems like ﬁrst pass effect associated with systemic delivery. In
this scenario, local treatment of C. vaginitis represents a
rational choice for its management.
Nystatin is a broad spectrum polyene antibiotic, produced
by Streptomyces noursei strains (Kaur and Kakkar, 2010). It
exerts its antifungal action by binding to sterols, chieﬂy ergos-
terol of the fungal cell membrane, and the formation of barrel-
like membrane-spanning channels (Coutinho and Prieto,
2003). Nystatin has both an antifungal and fungistatic activ-
ities (Recamier et al., 2010) and has been found to possess
broader spectrum of activity as compared to azole antifungals
(Das-Neves et al., 2008). Commercially, very few vaginal nys-
tatin formulations are available (Mycostatin, Nilstat,
Nadostine). These are cream formulations that suffer from
the drawbacks of being leaky and messy in nature and also
require a frequent dosing regimen owing to the self-cleansing
action of the vagina, namely the secretion of mucus and humid
site of administration (Valenta, 2005). In order to overcome
these problems researchers started working up on designing
of bioadhesive vaginal formulations, which would provide an
intimate contact of the formulation at target site, improve res-
idence time and thereby provide appropriate drug release char-
acteristics. Nystatin gels (Hombach et al., 2009) and
microparticulate (Martı´n-Villena et al., 2013) bioadhesive for-
mulations have been designed for vaginal delivery of nystatin,
however the release of nystatin from these formulations is
either too little (30% nystatin release from polyacrylic acid
cysteamine conjugate gels in 7 days) (Hombach et al., 2009)
or a burst release has been observed (Martı´n-Villena et al.,
2013), indicating a need towards the development of a
mucoadhesive formulation that would provide controlled drug
release and vaginal residence characteristics.
Response Surface Methodology (RSM) is widely used as a
tool for designing of experiments in the development and opti-
mization of drug delivery systems (Aberturas et al., 2002;
Singh et al., 2005a,b) including preformulation studies toPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015facilitate screening of excipients and to study the effects of dif-
ferent formulations and/or process variables on the drug
release or dissolution characteristics (Chopra et al., 2007;
Hooda et al., 2012; Mennini et al., 2008).
In the present study, Tamarind seed polysaccharide (TSP)
bioadhesive ﬁlms were prepared employing 32 randomized full
factorial design and optimized in terms of different properties
using RSM approach. The simultaneous evaluation of the
effects of formulation variables (polymer and plasticizer con-
centration) on mechanical, swelling and bioadhesive properties
of the ﬁlm was carried out to determine the optimum formula-
tion composition using RSM approach. TSP ﬁlms were tested
as drug carrier systems for vaginal delivery of nystatin. In vitro
drug release studies and residence time studies were carried out
to ensure appropriate drug release characteristics and vaginal
retention. The antifungal activity of vaginal ﬁlms was also
determined by observing the zone of inhibition produced
in vitro.
2. Material and method
2.1. Materials
Tamarind seed polysaccharide (TSP) was received as a gift sam-
ple from Encore Natural Polymer Pvt. Ltd (Naroda,
Ahmadabad, India). Propylene glycol (PG) was procured from
SDFine chemicals ltd, India.Nystatinwas received as a gift sam-
ple from DSM Sinochem Pharmaceuticals, India. Candida albi-
cans ATCC 10231 was purchased from Institute of Microbial
Technology (IMTECH), Chandigarh, India. All reagents and
chemicals were of analytical grade and used as received.
Simulated vaginal ﬂuid (SVF) was prepared according to
the previous literature report with the following composition
(g L1): NaCl, 3.51; KOH, 1.40; Ca(OH)2, 0.222; bovine serum
albumin, 0.018; lactic acid, 2.00; acetic acid, 1.00; glycerol,
0.160; urea, 0.400 and glucose, 5.00. The mixed solution was
adjusted to a pH of 4.2 (Owen and Katz, 1999).
2.2. Preparation of TSP ﬁlms
TSP ﬁlms were prepared by the solvent casting method
(Salamat-Miller et al., 2005). Brieﬂy TSP (1–2% w/v) was dis-
solved in distilled water on a magnetic stirrer (Remi equip-
ments, Mumbai India), this was followed by the addition of
plasticizer (PG; 15–20%v/v). The resulting viscous solution
(50 mL) was poured into polypropylene petri plates
(553.86 cm2). The petri plates were stored at 4 C for 24 h to
remove all the entrapped air bubbles (Mura et al., 2010) and
then dried in an oven (Narang Scientiﬁc Works Pvt. Ltd.,
New Delhi) at 50 C for 72 h. The dried ﬁlms were carefully
removed and checked for any imperfections or air bubbles
and stored in desiccator till use.
2.3. Experimental design for optimization
A 32 randomized full factorial design with replicated centre
point, consisting of 13 runs (Table 1), was used for optimiza-
tion of ﬁlms. Response surface methodology (RSM) was used
to investigate the effect of independent variables (TSP concen-
tration; X1 and PG (plasticizer) concentration; X2) on a range
of dependent variables. The independent variables werecarrier for bioadhesive drug delivery: Development, characterization and opti-
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Table 1 A 32 full factorial design with replicated centre point and the values obtained for different response variables.
Batch
no.
Independent variables Response/dependent variables
Coded factors Actual factors
TSPa
conc.
(A)
PGb
conc.
(B)
TSPa
conc.%
w/v
PGb
conc.%
v/v
Contact
angle ()
(Y1)
Spreading
coeﬃcient
(Y2)
Max
detachment
force (mN)
(Y3)
Tensile
strength
(N) (Y4)
%EBc
(Y5)
WVTRd
(g/hm2)
(Y6)
%
Swelling
indexe
(Y7)
T1 1 1 1.0 15.0 30.00 9.27 75.00 6.41 8.91 13.80 119.21
T2 1 0 1.0 17.5 34.00 11.83 76.00 6.38 9.37 12.50 105.38
T3 1 1 1.0 20.0 37.00 13.93 72.00 6.34 9.88 12.10 102.76
T4 0 1 1.5 15.0 21.00 4.60 79.00 7.92 9.39 14.30 128.22
T5 0 0 1.5 17.5 24.00 5.98 77.00 7.98 10.30 13.70 110.16
T6 0 1 1.5 20.0 27.00 7.54 73.00 7.86 10.47 13.50 106.36
T7 1 1 2.0 15.0 12.00 1.51 106.00 9.77 10.71 14.90 147.86
T8 1 0 2.0 17.5 14.00 2.06 104.00 9.82 10.78 14.50 138.65
T9 1 1 2.0 20.0 18.00 3.39 92.00 9.95 11.56 14.10 121.73
T10 0 0 1.5 17.5 24.00 5.98 76.00 7.89 10.51 13.70 108.26
T11 0 0 1.5 17.5 24.00 5.98 77.00 7.11 10.33 13.50 113.13
T12 0 0 1.5 17.5 25.00 6.22 77.00 7.82 10.24 13.70 121.49
T13 0 0 1.5 17.5 23.00 5.21 75.00 7.89 10.41 13.60 115.30
a TSP: tamarind seed polysaccharide.
b PG: propylene glycol.
c EB: elongation at break.
d WVTR: water vapour transmission rate.
e Swelling index values at the end of 6 h.
Polymeric ﬁlms as a promising carrier for bioadhesive drug delivery 3evaluated at three levels. The higher and lower levels of each
factor were coded as +1 and 1, respectively, and the mean
value as 0 (Table 1). Contact angle (Y1), spreading coefﬁcient
(Y2), bioadhesive strength (maximum detachment force) (Y3),
tensile strength (Y4), % elongation at break (%EB) (Y5), swel-
ling index (SI) (Y6) and water vapour transmission rate
(WVTR) (Y7) were used as dependent (response) variables
(Table 1). Design Expert trial version 8.0.7.1(Stat-ease Inc.,
Minneapolis, MN, USA) was used for performing experimen-
tal design, polynomial ﬁtting and ANOVA results.
Appropriate models were selected by comparing lacks of ﬁt p
values and R2 values. Graphs were plotted for statistically sig-
niﬁcant models with insigniﬁcant lacks of ﬁt at desired conﬁ-
dence levels. The formulations were optimized using
desirability approach to select optimum combination of for-
mulation variables (X1 and X2) that provide desired bioadhe-
sive and physical, mechanical and interfacial properties of
TSP ﬁlms.
2.4. Mass uniformity, thickness and folding endurance
Mass uniformity of the patches was tested using an electronic
digital balance (Precisa Gravimetric AG). Thickness of the
ﬁlms was measured at three different randomly selected posi-
tions using a digital vernier calliper and a mean value was cal-
culated. For testing folding endurance the ﬁlms were folded
manually at the same place, ﬁlms which got folded for P300
times without breaking were said to pass this test (Patel and
Poddar, 2009).
2.5. Swelling index (SI) measurement
The hydration characteristics of polymer play an important
role in bioadhesion. Agar plates (2% w/v agar in simulatedPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015vaginal ﬂuid (SVF)) were prepared and maintained at 37 C.
The initial diameter of individual ﬁlms was determined.
These were then allowed to swell on the surface of the agar
plates. The samples were removed at regular intervals and
the increase in the diameter of the ﬁlms was determined for
a period of 8 h. SI was calculated from the following formula:
%S ðSIÞ ¼ ðDt DoÞ=Do  100 ð1Þ
where %S is the % swelling, Dt and Do the diameter of the
swollen and original ﬁlm respectively after time (Mura et al.,
2010).
2.6. Determination of interfacial properties: contact angle and
spreading coefﬁcient measurement
Contact angle of SVF with surface of ﬁlms was obtained by
modiﬁcation of a method reported by Grzegorzewski et al.
(2010). A drop of SVF (200 lL) was placed gently on the
top of the ﬁlm surface with a micropipette from a distance
of 1 cm. Images were captured using a digital camera. The
angle between the tangent line of the drop and the ﬁlm surface
was calculated using Image J software. Spreading coefﬁcient at
the SVF and ﬁlm surface was calculated using the equation:
S ¼ cLðcos h 1Þ ð2Þ
where cL is the surface tension of SVF calculated using stalag-
mometer method (Jindal et al., 2013).
2.7. Determination of mechanical properties: tensile strength &
% elongation at break (%EB) measurement
The mechanical properties of ﬁlms were evaluated using tex-
ture analyser equipment equipped with a 10 Kg load cell
(TA.XT plus, Stable Micro Systems, UK) (Perumal et al.,carrier for bioadhesive drug delivery: Development, characterization and opti-
.06.003
Table 2 Lack of ﬁt p-value and R2 values for model selection of different response variables.
Sequential p-value R2 Adjusted R2 Predicted R2 Lack of ﬁt p-value Comments
Contact angle (Y1)
Linear <0.0001 0.9946 0.9935 0.9913 0.8367 Suggested
2FI 0.4094 0.9950 0.9934 0.9887 0.8273
Quadratic 0.8567 0.9952 0.9918 0.9807 0.6564
Cubic 0.4252 0.9966 0.9919 0.9869 0.7837 Aliased
Spreading coeﬃcient (Y2)
Linear <0.0001 0.9578 0.9494 0.9088 0.0450
2FI 0.0812 0.9705 0.9606 0.8882 0.0662
Quadratic 0.0020 0.9950 0.9914 0.9829 0.7676 Suggested
Cubic 0.5475 0.9960 0.9905 0.9873 0.8150 Aliased
Max detachment force (Y3)
Linear 0.0021 0.7091 0.6509 0.4515 0.0003
2FI 0.4480 0.7281 0.6375 0.1675 0.0002
Quadratic <0.0001 0.9905 0.9837 0.9373 0.0779 Suggested
Cubic 0.4463 0.9931 0.9835 0.4319 0.0359 Aliased
Tensile strength (Y4)
Linear <0.0001 0.9519 0.9423 0.9280 0.7645 Suggested
2FI 0.7013 0.9527 0.9370 0.8887 0.6977
Quadratic 0.1520 0.9724 0.9527 0.9539 0.9849
Cubic 0.9759 0.9727 0.9344 0.8847 0.7692 Aliased
%EB (Y5)
Linear <0.0001 0.9298 0.9157 0.8858 0.0601 Suggested
2FI 0.7833 0.9304 0.9072 0.8642 0.0463
Quadratic 0.6282 0.9390 0.8955 0.5984 0.0277
Cubic 0.7059 0.9470 0.8727 4.2936 0.0080 Aliased
WVTR (Y6)
Linear <0.0001 0.9183 0.9020 0.8181 0.0190
2FI 0.0470 0.9486 0.9314 0.8605 0.0343
Quadratic 0.0808 0.9749 0.9570 0.7869 0.0637 Suggested
Cubic 0.0169 0.9951 0.9882 0.9784 0.7615 Aliased
Swelling index (Y7)
Linear 0.0002 0.8242 0.7890 0.6894 0.3097
2FI 0.4618 0.8350 0.7800 0.4729 0.2768
Quadratic 0.0386 0.9349 0.8884 0.7713 0.7350 Suggested
Cubic 0.5502 0.9487 0.8769 0.6491 0.6801 Aliased
4 P. Bassi, G. Kaur2008). A ﬁlm strip of area 10 cm2 was held between two clamps
of texture analyser probe positioned 3 cm apart. The ﬁlm strip
was pulled by the upper arm (trigger load 0.05 N) at the rate of
5.0 mm/s to a distance of 100 mm before returning to the start-
ing point. The force required to break the ﬁlm and the elonga-
tion at break were measured. The calculations were performed
using Texture-Pro CT V1.3 Build 14 software (Heng et al.,
2003).
2.8. Determination of bioadhesive strength/maximum
detachment force
The in vitro bioadhesive strength was evaluated using a texture
analyser equipment (TA.XT plus, Stable Micro Systems, UK)
equipped with a 100 g load cell. Fresh porcine vaginal mucosa
was used as a model membrane. The mucosal membrane was
obtained from slaughter house was thoroughly cleaned by
removing the underlying connective tissue and washed with
SVF. It was mounted securely in place on a membrane tissue
holder and wetted with 0.1 mL of SVF. The mucosa was
exposed to the probe through a circular disc having a cavityPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015of diameter 1.27 cm. A sample of the prepared TSP ﬁlm
(1 cm2) was attached (using double sided adhesive tape) to
the base of the cylindrical probe, which was ﬁxed to the mobile
arm of the texture analyser. The cylindrical probe with the ﬁlm
attached to its base was lowered onto the circular disc at a
speed of 0.5 mm/s and a force of 1 N for a contact time of
30 s. It was then withdrawn at a rate of 0.5 mm/s to a distance
of 10 mm. The mucoadhesive performance of the samples was
determined by measuring the resistance to the withdrawal of
the probe (maximum detachment force) reﬂecting the bioadhe-
sive characteristics of the TSP ﬁlm (Eouani et al., 2001).
2.9. Determination of water vapour transmission rate (WVTR)
The WVTR (g m2 h1) of TSP ﬁlms was determined using a
vapometer (Delﬁn Technologies Ltd., Kuopio, Finland).
Films were mounted and sealed on the top of open specially
designed beakers ﬁlled with 8.9 mL of distilled water. The sys-
tem was then equilibrated for 2 h at room temperature
(25 ± 2 C, 42–46% RH) and thereafter WVTR was measured
(Silva et al., 2008).carrier for bioadhesive drug delivery: Development, characterization and opti-
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Table 3 ANOVA results for the selected models for different responses.
Response Source Sum of squares DFa Mean square F value p-Value Prob > F Comments
Y1 Quadratic model 2004.0362 5 400.8072 433.1556 <0.0001 Signiﬁcant
Lack of ﬁt 4.8320 3 1.6107 3.9158 0.1102 Not signiﬁcant
Y2 Linear model 0.7029 2 0.3514 83.2927 <0.0001 Signiﬁcant
Lack of ﬁt 0.0121 6 0.0020 0.2685 0.9257 Not signiﬁcant
Y3 Linear model 601.6667 2 300.8333 923.8189 <0.0001 Signiﬁcant
Lack of ﬁt 1.2564 6 0.2094 0.4188 0.8367 Not signiﬁcant
Y4 Quadratic model 151.97284 5 30.3946 277.0218 <0.0001 Signiﬁcant
Lack of ﬁt 0.1737 3 0.0579 0.3897 0.7676 Not Signiﬁcant
Y5 Quadratic model 1576.1244 5 315.2249 146.0696 <0.0001 Signiﬁcant
Lack of ﬁt 11.9063 3 3.9688 4.9610 0.0779 Not signiﬁcant
Y6 Linear model 18.0618 2 9.0309 98.9858 <0.0001 Signiﬁcant
Lack of ﬁt 0.4065 6 0.0677 0.5356 0.7645 Not signiﬁcant
Y7 Linear model 5.3870 2 2.6935 66.1823 <0.0001 Signiﬁcant
Lack of ﬁt 0.3631 6 0.0605 5.5166 0.0601 Not signiﬁcant
Y8 Quadratic model 6.5291 5 1.3058 54.4593 <0.0001 Signiﬁcant
Lack of ﬁt 0.1358 3 0.0453 5.6602 0.0637 Not signiﬁcant
Y9 Quadratic model 2022.0026 5 404.4005 20.1006 0.0005 Signiﬁcant
Lack of ﬁt 35.1430 3 11.7143 0.4434 0.7350 Not signiﬁcant
a DF: degree of freedom.
Polymeric ﬁlms as a promising carrier for bioadhesive drug delivery 52.10. Preparation of drug loaded ﬁlms
The optimized TSP blank ﬁlms were loaded with nystatin a
‘polyene antibiotic’. It is commercially available as a mixture
of three different constituents (A1, A2, A3). Nystatin sample
containing >90% of constituent A1 with a potency of
6830 units/mg as speciﬁed and supplied by the manufacturer
was used in the present study.
For the preparation of drug loaded TSP ﬁlms nystatin
(10,000 units) was dispersed either alone (ﬁlm code T14D) or
in a ratio of 1:0.5 (ﬁlm code T14DT0.5) and 1:1 with Tween 60
(ﬁlm code T14DT) in water. Tween 60 was used as a solubilizing
agent for nystatin (Tallury et al., 2007). The nystatin dispersion
was poured into TSP solution containing PG. The solutions
were mixed and poured into petri-plates, which were stored at
4 C for 24 h and subsequently dried in an oven (Narang
Scientiﬁc Works Pvt. Ltd., New Delhi) at 50 C for 72 h.
2.11. Physiochemical interaction studies
2.11.1. Differential scanning calorimetry
The physicochemical interaction among drug and other excip-
ients incorporated in the ﬁlm was characterized by carrying
out the DSC (Mettler Toledo 812E, Switzerland) studies.
TSP ﬁlms were heated at a heating rate of 10 C min1 in
the heating range of 30–400 C under nitrogen atmosphere.
2.11.2. Scanning electron microscope characterization of ﬁlms
The morphological characteristics of blank, drug loaded and
drug and Tween loaded TSP ﬁlms were examined using a
JEOL JSM-6610 LV scanning electron microscope (SEM)
(JEOL Ltd., Tokyo, Japan) operated at 15 kV. The ﬁlms were
coated with a layer of gold under argon atmosphere for 70 s
prior to imaging at different magniﬁcations.Please cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.20152.12. Drug content uniformity
The uniformity of drug distribution in ﬁlms was determined
1 cm2 patches of T14DT ﬁlms from ﬁve different locations.
The patch was weighed, homogenized (Remi equipments,
Mumbai, India) and dissolved in SVF with continuous
stirring on a magnetic stirrer to extract the drug. The
drug content was determined using the standard plot of
nystatin.
2.13. In vitro drug release and residence time
In vitro drug release studies were carried out using simulated
dynamic vaginal system (Yoo et al., 2006). This system is based
upon the rate of secretion and maximum volume of mucus in
the vagina. Freshly isolated porcine vaginal tissue, obtained
from slaughter house, was cleaned, and cut into size of
5 · 5 cm2. The vaginal mucosa was mounted on a glass slide
inclined at an angle of 30 with the mucosal side facing
upwards. The optimized drug loaded TSP ﬁlm (size 1 cm2)
was mounted on the mucosal membrane. SVF was allowed
to ﬂow on the ﬁlm at a rate of 5 mL h1 with the help of a peri-
staltic pump (Electrolab, PP201V, Mumbai, India). A ﬂask
was placed under the glass slide and the perfused SVF was col-
lected, at predetermined time intervals. The absorbance of the
samples was measured at 306 nm using UV–Vis spectropho-
tometer and the drug release was determined by extrapolation
from the calibration curve. Residence time of the ﬁlms on the
vaginal mucosa was also determined by using the same method
(Yoo et al., 2006).
The drug release proﬁles were ﬁtted into different models to
determine the kinetics and mechanism of drug release. The best
ﬁt model was determined on the basis of value of coefﬁcient of
linear correlation (R2) (Costa and Lobo, 2001).carrier for bioadhesive drug delivery: Development, characterization and opti-
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Figure 1 Response surface plots for responses namely (a) contact angle, (b) spreading coefﬁcient, (c) WVTR, and (d) swelling index.
Table 4 Values of coefﬁcients obtained for variables X1 and X2 in the equations generated for different response variables.
a
Coeﬃcient value Contact angle Spreading coeﬃcient Maximum detachment force Tensile strength %EB WVTR Swelling index
b0 24.08 5.89 76.86 7.93 10.22 13.64 114.05
b1 9.50 4.68 13.17 1.74 0.82 0.85 13.48
b2 3.17 1.58 3.83 8.33E003 0.48 0.55 10.74
b3 0.00 0.70 2.75 0.00 0.00 0.23 2.42
b4 0.00 1.02 11.98 0.00 0.00 0.16 7.02
b5 0.00 0.14 2.02 0.00 0.00 0.24 2.30
a The b3, b4, b5 coefﬁcient values of contact angle, tensile strength and %EB are zero since they were found to have a linear ﬁt.
6 P. Bassi, G. Kaur2.14. In vitro antifungal activity
Agar diffusion method was used for in vitro antifungal activity
testing. Freeze dried samples of C. albicans (MTCC 227), were
revived on Malt Extract Glucose Yeast Extract Peptone Broth
media (MGYPB) and stored at 4 C. The yeast was sub-
cultured in Sabouraud Dextrose Agar (SDA) media, 48 h prior
to antifungal activity testing. Stock inoculum suspension was
prepared in sterile saline from the subculture and was adjusted
to 0.5 McFarland turbidity standards to get an approximate
concentration of 1 · 108 CFU mL1. The prepared SDA plates
were inoculated with 0.1 mL of C. albicans suspension and
spread uniformly with the help of a sterile spreader. BlankPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015and drug loaded ﬁlms were placed onto inoculated media
plates. Tween solubilized nystatin in SVF was used as a posi-
tive control. In this case, nystatin solution equivalent to
10,000 units of nystatin, was placed in wells bored in previ-
ously inoculated SDA plates. These plates were maintained
at 4 C for 2 h before incubating them at 37 C for 24 h. The
zone of inhibition (ZOI) was determined using zone reader
(Moussa et al., 2012).
2.15. Stability studies
Accelerated stability studies were carried out using a stability
chamber maintained at 40 ± 0.5 C and 75 ± 5% RH.carrier for bioadhesive drug delivery: Development, characterization and opti-
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Figure 2 Response surface plots for responses namely (a) tensile strength, (b) max detachment force, and (c) %EB (% elongation at
break).
Figure 3 Overlay plot of all response variables showing the
region of desirability.
Polymeric ﬁlms as a promising carrier for bioadhesive drug delivery 7T14DT ﬁlms were wrapped in aluminium foil and stored in a
glass container for 6 months in the stability chamber. They
were evaluated for mass uniformity, thickness, folding endur-
ance, drug content uniformity and % drug release at 0, 3Please cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015and 6 month time intervals (Palem et al., 2011; Patel and
Poddar, 2009).
3. Results and discussions
3.1. Preparation of TSP ﬁlms
TSP was found to display adequate ﬁlm forming properties.
The developed ﬁlms were smooth and uniform in texture.
The mass of prepared TSP ﬁlms ranged from 57.18 ± 1.23
to 98.00 ± 1.28 mg, while thickness was found to be in the
range of 1.52 ± 0.25 to 2.31 ± 0.09 mm. All the prepared
ﬁlms passed the folding endurance test.
3.2. Response Surface Methodological Optimization
A 32 randomized full factorial design with centre point repli-
cated four times, consisting of 13 runs (3 · 3 + 4 = 13)
(Table 1) was designed and the effect of independent variables
(TSP concentration; X1 and PG (plasticizer) concentration; X2)
was studied on the response variables (Y1–Y7) using Design
Expert software trial version 8.0.7.1(Stat-ease Inc.,carrier for bioadhesive drug delivery: Development, characterization and opti-
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Figure 4 Linear correlation plots between actual and predicted values for different check point formulations for different responses.
8 P. Bassi, G. KaurMinneapolis, MN, USA). The replicate experiments were
included in the design to determine whether the effect of
changing factor levels is signiﬁcantly larger than the effect of
experimental error on responses (Santosa et al., 2005).
Table 1 depicts the values of different response variables
obtained for different formulations. The obtained values were
ﬁtted into different models namely linear, 2FI (2 factor inter-
action), Quadratic and cubic using Design Expert software
and a suitable model was selected based on lack of ﬁt p-
value and R2 values. The different model ﬁtting values are
shown in Table 2. Lack of ﬁt values depicted in the Table is
indicative of how effectively the model ﬁts the data. It mea-
sures residual error to pure error. A signiﬁcant lack of ﬁt
(p< 0.05) is an undesirable property, because it suggests that
the model does not ﬁt the data well and hence should not be
used for further predictions. Models chosen for responses
Y1–Y7 had an insigniﬁcant lack of ﬁt. The value of correlation
coefﬁcient (R2) is also an indication of the appropriateness of
the selected model. Adjusted R2 represents the amount of vari-
ation that can be explained by the model. Predicted R2Please cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015represents the amount of variation in predicted values
explained by the model. In the present study, the predicted
R2 and the adjusted R2 of the selected models are within
0.20 (as shown in Table 2) of each other indicating appropri-
ateness of the selected models. A quadratic model was selected
for responses Y2, Y3, Y6, Y7 and linear model was selected for
responses Y1, Y4 and Y5. The statistical validity of the
selected models was further established by ANOVA. The
results are summarized in Table 3. From the table it can be
observed that for all the responses, the model terms are signif-
icant (p< 0.05) and they have an insigniﬁcant lack of ﬁt,
which implies that the selected models are statistically signiﬁ-
cant and can be used for prediction of responses. The %CV
and adequate precision values for responses Y1–Y7 were
2.37 and 92.413, 5.16 and 55.62, 1.80 and 35.637, 3.81 and
24.029, 1.97 and 26.794, 1.13 and 26.616, 3.79 and 15.897,
respectively.
Eq. (3) is a generalized equation representing the relation-
ship between dependent variable (Y) and independent variable
(X1 and X2) obtained for all the responses. The coefﬁcients ofcarrier for bioadhesive drug delivery: Development, characterization and opti-
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Figure 5 Physicochemical interactions between blank (T14) and
drug loaded TSP ﬁlms with nystatin and Tween in ratio of 1:0
(T14D), 1:0.5 (T14DT0.5) and 1:1 (T14DT).
Polymeric ﬁlms as a promising carrier for bioadhesive drug delivery 9the variables X1 and X2 in Eq. (3) for different responses are
compiled in Table 4.
Y ¼ b0 þ b1X1 þ b2X2 þ b3X1X2 þ b4X21 þ b5X22 ð3Þ
An increase in the polymer (TSP) concentration has a pos-
itive impact on the spreading coefﬁcient, maximum force
required for detachment, tensile strength, %EB, WVTR andFigure 6 Surface morphology of blank (a), drug loaded TSP ﬁlms w
Please cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015swelling index. However, a decrease in the value of contact
angle was observed with an increase in TSP. The swelling
index, spreading coefﬁcient, WVTR and maximum force
required for detachment properties of a polymer are a function
of the number of hydrophilic groups available for interaction
with the mucus. An increase in the concentration of polymer
increases the number of available groups, thereby increasing
the magnitude of these properties. Further, an increase in poly-
mer concentration also improves the contact with mucus which
leads to a decrease in contact angle values (Patel et al., 2011;
Salamat-Miller et al., 2005). An increase in plasticiser concen-
tration increases the hydrophobic character of the ﬁlms (Orliac
et al., 2003) resulting in a decreased afﬁnity between ﬁlm sur-
face and mucus membrane and therefore a trend opposite to
that of increasing polymer concentration was observed
(Andrews et al., 2009; Edsman and Hagerstrom, 2005).
These interactive effects of the formulation variable on the
response variable can be easily visualized by 3D plots shown
in Figs. 1 and 2. For swelling index studies ﬁlms containing
1% TSP eroded at the end of 6 h while others remained intact
till the end of the study.
After establishment and analysis of appropriate models for
individual responses, the simultaneous optimization of multi-
ple responses was carried out using Design-Expert software
to ﬁnd a combination of factor levels that simultaneously sat-
isfy the requirements placed on each of the responses and fac-
tors. This process identiﬁes those areas in design region where
the system is likely to give desirable responses (Espinoza-
Escalante et al., 2007; Vera-Candioti et al., 2006). This was
done graphically by overlaying critical response contours on
a contour plot and identifying area of feasible response values
in the factor space (yellow/lighter area in Fig. 3) as well as
numerically by using desirability approach. For calculating
desirability function, a desired goal (maximum, minimum,ith nystatin and Tween in ratio of 1:0 (b), 1:0.5 (c), and 1:1 (d).
carrier for bioadhesive drug delivery: Development, characterization and opti-
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and response variable. The goals are then combined into a
simultaneous objective function, desirability, ‘D’ which is a
geometric mean of all transformed responses, calculated
according to the following formula:
D ¼ dr11 þ dr21 . . . . . . drn1
  1
Rr1 ¼
Yn
i¼1
dr1i
 ! 1
Rr1
ð4Þ
where (di) is the desirable range for each response, (ri) is the
importance attached to various responses and (n) is the num-
ber of responses. Desirability is an objective function that
ranges from zero (least desirable) to one (most desirable).
Desirability is only a mathematical method to ﬁnd the opti-
mum, therefore, the goal of this optimization was to ﬁnd a
point that maximizes the desirability function, and meet goals
set for all responses, and not just to obtain a high value. In the
present research, after goal setting of all the responses, the
maximum value of desirability was found to be 0.400. The
optimization step gave 6 check point formulations in the desir-
able range and predicted 2% TSP and 15.3% v/v PG as the
most desirable formulation. The other desirable formulations
compositions in decreasing order of desirability were 2%
TSP: 15.3% v/v PG> 2% TSP: 15.5% v/v PG> 2% TSP:
15.8% v/v PG> 2% TSP: 16.5% v/v PG> 2% TSP:
15.2% v/v PG.
3.3. Experimental veriﬁcation
The check point formulations and their predicted responses
were veriﬁed experimentally. All the formulations were pre-
pared and the values of response variables were found out
experimentally. The model predicted values were then com-
pared with actual values obtained after experimentation and
the percentage error in prognosis was calculated. The error
was found to vary between 1.8352% and 1.8017%. Linear
correlation plot between the actual and the predicted response
variables is shown in Fig. 4. The plot demonstrated a high val-
ues of R2 (ranging 0.9095–0.9975) indicating excellent good-
ness of ﬁt (p< 0.001). Thus, the low magnitude of
percentage error, as well as the signiﬁcant values of R2 in the
present investigation, proved the high predictability of the
RSM. Further, a two tailed t-test was also applied to the pre-
dicted and actual values of all the responses and it was found
that the difference in the two values was statistically insigniﬁ-
cant, which further conﬁrms the predictability of the designed
model. Based on the above ﬁndings formulation containing
2% TSP and 15.3% v/v PG (ﬁlm code T14) was selected for
drug loading and further studies. The ﬁlm was loaded with
nystatin (ﬁlm code T14D) alone or in combination with
Tween 60. Tween 60 was incorporated into the ﬁlms to aid sol-
ubilization of nystatin in the ratio of 1:0.5 (ﬁlm code
T14DT0.5) and 1:1 (ﬁlm code T14DT) nystatin to Tween ratio.
3.4. Physiochemical interaction studies
Fig. 5 shows the DSC proﬁles of T14, T14D, T14DT0.5, T14DT
and nystatin. The thermal behaviour of the ﬁlms can provide an
insight into the drug–polymer compatibility, miscibility and
any alteration in the chemical structure of either polymer or
drug. DSC of pure nystatin revealed an endotherm which peaksPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015at 173 C with corresponding DH value of 238 J g1. DSC of
T14 ﬁlm shows an initial endotherm followed by an exotherm
with peaks at 120 C and 309 C, respectively. When nystatin
was incorporated into the ﬁlm (T14D) an additional sharp peak
corresponding to the melting peak of nystatin is observed at
172 C (DH= 155 J g1) indicating the presence of crystalline
un-solubilized drug. This peak however, reduced in intensity
and enthalpy (DH= 64 J g1) with the addition of small quan-
tity of Tween (T14DT0.5) and completely disappeared when the
quantity of Tween was increased (T14DT). The decline in
enthalpy and intensity indicates only partial solubilization of
nystatin in the ﬁlm indicating that 1:0.5 ratio of drug to
Tween is not sufﬁcient to cause complete solubilization of the
incorporated drug. The absence of nystatin melting peak in
T14DT indicates transformation of crystalline drug into amor-
phous state as a consequence of solubilization effect of Tween.
Tween 60 was able to cause micellar solubilization of nystatin.
This conclusion can be further supported by the fact that the
concentration of Tween 60 used in T14DT was greater than
its critical micellar concentration value (30 lg mL1) thus,
ensuring formation of micelles and nystatin solubilization
(Tallury et al., 2007).
SEM analysis of the ﬁlm (Fig. 6) also conﬁrmed the above
ﬁndings. Blank TSP ﬁlms (T14) (Fig. 6a) showed smooth tex-
ture indicating uniformity of polymer matrix. The un-
solubilized drug particles were clearly evident in T14D ﬁlms
(Fig. 6b). Addition of Tween in T14DT0.5 (Fig. 6c) partially
solubilized nystatin and also created some smoothness in the
ﬁlm texture, while a completely smooth texture with no visible
drug particles was observed for T14DT ﬁlms (Fig. 6d). Based
on the above ﬁndings that T14DT ﬁlms were used for drug
release studies.
3.5. Drug content uniformity, in vitro drug release and residence
time
The drug content of T14DT was found to be 98.23 ± 0.67%
suggesting that the ﬁlm casting process led to the development
of ﬁlms with uniform drug dispersion.
The in vitro drug release studies were carried out on T14DT
ﬁlms loaded with nystatin solubilized with Tween. Samples
were collected at ﬁxed intervals, and the amount of nystatin
released from the formulation with respect to time was calcu-
lated. The bioadhesive ﬁlm formulation was releasing
73.92 ± 2.54% of nystatin (Fig. 7) at the end of 8 h. Release
data from the ﬁlms was subjected to model ﬁtting equations
namely, zero order, ﬁrst order, Higuchi, Weibull and
Korsmeyer–Peppas model in order to determine the rate ofFigure 7 Nystatin release proﬁle for TSP ﬁlms.
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Table 5 Stabiliy studies for T14DT ﬁlms.
Parameter 0 Month 3 Months 6 Months
Mass (mg) 103.4 ± 1.04 103.4 ± 0.70 102.73 ± 0.56
Thickness (mm) 2.04 ± 0.03 2.03 ± 0.02 2.03 ± 0.02
Folding endurance >300 >300 >300
% Drug content 98.23 ± 0.67 98.29 ± 0.64 98.21 ± 0.68
% Drug release 73.92 ± 2.54 73.49 ± 0.99 73.24 ± 0.74
Polymeric ﬁlms as a promising carrier for bioadhesive drug delivery 11drug release. The release data showed best ﬁt to Korsmeyer–
Peppas model with R2 of 0.9996. The value of release exponent
n was calculated to be 1.19, suggesting the release mechanism
to be super case-II.
Residence time of the formulation was found to be about
510 ± 5 min.
3.6. In vitro antifungal activity
Tamarind has been shown to possess antifungal activity
against C. albicans. This activity has been ascribed to the pres-
ence of some essential oils or secondary metabolites. However,
several other studies have completely ruled out any such activ-
ity (Debnath et al., 2011; Doughari, 2006; Escalona-Arranz
et al., 2010). In order to explore this fact and to see whether
TSP can exert any synergistic anti candida activity along with
the nystatin incorporated in the ﬁlm, blank TSP ﬁlms were
subjected to antifungal activity testing. Films with different
TSP concentrations (1%, 1.5%, 2% w/v TSP) namely T1, T4
and T7 were placed on the inoculated SDA plates and were
observed for appearance of ZOI at the end of the study. No
ZOI was observed for the blank TSP ﬁlms. Absence of ZOI
in blank TSP ﬁlms may be correlated with loss of essential
oil/secondary metabolites (which are proposed to have antifun-
gal activity in the literature) during the extraction process of
TSP. Thus, synergistic antifungal effect from the polymer
can be ruled out in drug loaded TSP ﬁlms in the present study.
For antifungal activity of drug loaded ﬁlms, T14DT ﬁlms
were placed on the inoculated SDA plates and were observed
for appearance of ZOI against T14 ﬁlms and nystatin solution
acting as the negative and positive control groups respectively.
A ZOI of 1.1 ± 0.2 cm was observed for T14DT ﬁlms. ZOI for
nystatin solution was 1.5 ± 0.1 cm, while no ZOI was
observed for T14 ﬁlms. These results indicate antifungal char-
acteristics of the prepared ﬁlm.
3.7. Stability studies
For assessment of ﬁlm stability three time points (0, 3,
6 months) were used. T14DT was assessed for mass unifor-
mity, thickness, folding endurance, drug content and % drug
release at each time point. The results are shown in Table 5.
No signiﬁcant difference (p< 0.05) was observed in these
properties indicating that the ﬁlms remained stable throughout
the study period.
4. Conclusion
Bioadhesive vaginal ﬁlms containing tamarind seed polysac-
charide were successfully prepared and characterized for their
bioadhesive, mechanical, swelling and interfacial propertiesPlease cite this article in press as: Bassi, P., Kaur, G. Polymeric ﬁlms as a promising
mization. Saudi Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015and optimized using response surface methodology. The
results of RSM optimization indicated that the formulation
containing 2% TSP and 15.3% v/v PG possessed most desir-
able properties. The optimized formulation was loaded with
micellar solubilized nystatin. These were able to release
73.92 ± 2.54% of nystatin and also exhibited appropriate res-
idence time in vitro. The drug release followed Korsmeyer–
Peppas kinetics with R2 of 0.9990. The optimized ﬁlm also
showed appropriate anti candida activity through appearance
of zone of inhibition during antifungal activity testing study.
Thus, the developed TSP ﬁlms can be proposed as a beﬁtting
candidate for vaginal delivery of drugs.
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